Business & Profession

Purchase of the ex-US rights for Fovista is costing Novartis US$200 million down and up to a cool US$1 billion in milestone payments

At last, a unique and useful function for femtosecond laser systems has emerged.

Increasing the light intensity over the thinnest point of the cornea – the periphery –improves outcomes of corneal collagen cross-linking in keratectasia patients.

A new technology that measures subjective refraction based on point spread function targets generates better data, increases efficiency in the clinic and improves patient outcomes.

Uveal and skin melanoma originate in the same type of cell, but are very different in terms of molecular mechanism, pathobiology, prognosis and therapeutic strategy. Here, the features of uveal melanoma are described and the latest therapeutic developments discussed.

If you had your time again, would you go to medical school, and would you choose ophthalmology?

Around since the 1950s, it has now been proven to improve visual outcomes in patients with idiopathic intracranial hypertension

To shave $2.7 billion from costs there will be substantial cuts and job losses

Certain patients don't get the treatment that they need. A little understanding and forward planning can solve the problem.

Sitting Down With Dan Myers, President and CEO of Alimera Sciences, Inc.